Your browser doesn't support javascript.
loading
Adipose Tissue Inflammation Is Not Related to Adipose Insulin Resistance in Humans.
Espinosa De Ycaza, Ana Elena; Søndergaard, Esben; Morgan-Bathke, Maria; Lytle, Kelli; Delivanis, Danae A; Ramos, Paola; Carranza Leon, Barbara Gisella; Jensen, Michael D.
Afiliação
  • Espinosa De Ycaza AE; Endocrine Research Unit, Mayo Clinic, Rochester, MN.
  • Søndergaard E; Facultad de Medicina, Universidad de Panamá, Panama City, Republic of Panama.
  • Morgan-Bathke M; Panamanian Institute of Biological Research, Panama City, Republic of Panama.
  • Lytle K; Endocrine Research Unit, Mayo Clinic, Rochester, MN.
  • Delivanis DA; Steno Diabetes Center Aarhus, Aarhus, Denmark.
  • Ramos P; The Danish Diabetes Academy, Odense, Denmark.
  • Carranza Leon BG; Endocrine Research Unit, Mayo Clinic, Rochester, MN.
  • Jensen MD; Nutrition and Dietetics, Viterbo University, La Crosse, WI.
Diabetes ; 71(3): 381-393, 2022 03 01.
Article em En | MEDLINE | ID: mdl-34857544
ABSTRACT
The role of adipose tissue (AT) inflammation in AT function in humans is unclear. We tested whether AT macrophage (ATM) content, cytokine gene expression, and senescent cell burden (markers of AT inflammation) predict AT insulin resistance measured as the insulin concentration that suppresses lipolysis by 50% (IC50). We studied 86 volunteers with normal weight or obesity at baseline and a subgroup of 25 volunteers with obesity before and after weight loss. There was a strong positive relationship between IC50 and abdominal subcutaneous and femoral fat cell size (FCS). The positive, univariate relationships between IC50 and abdominal AT inflammatory markers CD68, CD14, CD206 ATM/100 adipocytes, senescent cells, IL-6, and TNF-α mRNA were not significant after adjustment for FCS. A 10% weight loss significantly reduced IC50; however, there was no reduction in adipose ATM content, senescent cells, or cytokine gene expression. Our study suggests that commonly used markers of AT inflammation are not causally linked to AT insulin resistance, whereas FCS is a strong predictor of AT insulin resistance with respect to lipolysis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Tecido Adiposo / Inflamação / Obesidade Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Tecido Adiposo / Inflamação / Obesidade Idioma: En Ano de publicação: 2022 Tipo de documento: Article